QVEKLY Trademark

Trademark Overview


On Thursday, March 28, 2019, a trademark application was filed for QVEKLY with the United States Patent and Trademark Office. The USPTO has given the QVEKLY trademark a serial number of 88360418. The federal status of this trademark filing is REGISTERED as of Tuesday, May 23, 2023. This trademark is owned by Ascendis Pharma Endocrinology Division A/S. The QVEKLY trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Medical Instrument Products categories with the following description:

Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and pe...

Pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases

Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispenser...
qvekly

General Information


Serial Number88360418
Word MarkQVEKLY
Filing DateThursday, March 28, 2019
Status700 - REGISTERED
Status DateTuesday, May 23, 2023
Registration Number7057988
Registration DateTuesday, May 23, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2020

Trademark Statements


Goods and ServicesDownloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to growth disorders, endocrine disorders, bone disorders, cancer, infectious diseases and the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases for use by patients with growth hormone disorders, hypoparathyroidism, skeletal dysplasia, and diabetes in the medical field of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; downloadable computer application software for mobile phones, tablet computers handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases
Goods and ServicesPharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency, endocrine disorders, bone disorders, cancer, and infectious diseases
Goods and ServicesMedical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, cancer, and infectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, April 15, 2019
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, April 15, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAscendis Pharma Endocrinology Division A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressHellerup 2900
DK

Party NameAscendis Pharma Endocrinology Division A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHellerup 2900
DK

Party NameAscendis Pharma Endocrinology Division A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHellerup 2900
DK

Trademark Events


Event DateEvent Description
Tuesday, May 23, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 23, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, April 20, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, April 13, 2023NOTICE OF ALLOWANCE CANCELLED
Thursday, April 13, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, October 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 25, 2022SOU EXTENSION 5 GRANTED
Friday, October 7, 2022SOU EXTENSION 5 FILED
Monday, October 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 7, 2022TEAS EXTENSION RECEIVED
Thursday, April 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 12, 2022SOU EXTENSION 4 GRANTED
Tuesday, April 12, 2022SOU EXTENSION 4 FILED
Tuesday, April 12, 2022TEAS EXTENSION RECEIVED
Thursday, September 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 14, 2021SOU EXTENSION 3 GRANTED
Tuesday, September 14, 2021SOU EXTENSION 3 FILED
Tuesday, September 14, 2021TEAS EXTENSION RECEIVED
Wednesday, April 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 12, 2021SOU EXTENSION 2 GRANTED
Monday, April 12, 2021SOU EXTENSION 2 FILED
Monday, April 12, 2021TEAS EXTENSION RECEIVED
Thursday, October 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 13, 2020SOU EXTENSION 1 GRANTED
Tuesday, October 13, 2020SOU EXTENSION 1 FILED
Tuesday, October 13, 2020TEAS EXTENSION RECEIVED
Thursday, June 4, 2020ASSIGNED TO EXAMINER
Tuesday, April 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 7, 2020ASSIGNED TO LIE
Monday, December 16, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, September 13, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, September 13, 2019LETTER OF SUSPENSION E-MAILED
Friday, September 13, 2019SUSPENSION LETTER WRITTEN
Wednesday, September 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 4, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, June 12, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 12, 2019LETTER OF SUSPENSION E-MAILED
Wednesday, June 12, 2019SUSPENSION LETTER WRITTEN
Wednesday, June 12, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, June 12, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 12, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, June 12, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 11, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2019NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2019NON-FINAL ACTION WRITTEN
Sunday, June 9, 2019ASSIGNED TO EXAMINER
Monday, April 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 1, 2019NEW APPLICATION ENTERED